Zobrazeno 1 - 10
of 168
pro vyhledávání: '"Craig V. Comiter"'
Publikováno v:
Continence, Vol 11, Iss , Pp 101323- (2024)
Externí odkaz:
https://doaj.org/article/9186373c89b649d491ab14e6f487099c
Autor:
Raveen Syan, Mason A. Briggs, John C. Olivas, Sakti Srivastava, Craig V. Comiter, Amy D. Dobberfuhl
Publikováno v:
Investigative and Clinical Urology, Vol 60, Iss 1, Pp 40-45 (2019)
Purpose: OnabotulinumtoxinA (BTX) detrusor chemodenervation is an efficacious third-line treatment for overactive bladder. Despite high clinical efficacy rates for BTX injection, many patients refuse initial or repeat treatment due to the invasivenes
Externí odkaz:
https://doaj.org/article/ebf093d7c02d46fbb785ac7ad71ebe8c
Autor:
Craig V. Comiter, Amy D. Dobberfuhl
Publikováno v:
Investigative and Clinical Urology, Vol 57, Iss 1, Pp 3-13 (2016)
Surgery is the most efficacious treatment for postprostatectomy incontinence. The ideal surgical approach depends on a variety of patient factors including history of prior incontinence surgery or radiation treatment, bladder contractility, severity
Externí odkaz:
https://doaj.org/article/93ac754a14714181b240b9c8fb92ee60
Publikováno v:
The Scientific World Journal, Vol 4, Pp 357-363 (2004)
Introduction: Bladder neck suspension (BNS) for stress urinary incontinence (SUI) can have significant morbidity, including bleeding, infection and pain. In an effort to reduce this potential morbidity, we have devised a technique which provides the
Externí odkaz:
https://doaj.org/article/78a04b0cd65b4b2ea8e3fb5a0a1c43cd
Autor:
Ghazal Ameli, Emmanuel Jean Chartier-Kastler, Ralf G. Anding, Frank Van der Aa, Craig V. Comiter, Wilhelm A Hübner
Publikováno v:
Continence Reports. :100028
Autor:
Craig V. Comiter, Jennifer Gruenenfelder, Jeffrey Mangel, Howard B. Goldman, Stefan De Wachter, Andrea Pezzella, Bertil F.M. Blok, Mahreen Pakzad, Chris Taylor, Kenneth M. Peters, Felicia Lane, Michael J. Kennelly, Rebecca McCrery, Osvaldo Padron, Margaret G. Mueller, Marie Aimée Perrouin-Verbe, Philip Van Kerrebroeck, Andrew Shapiro, Una Lee, Kevin Benson
Publikováno v:
Neurourology and urodynamics, vol 40, iss 2
Neurourology and Urodynamics, 40(2), 714-721. Wiley
Neurourology and urodynamics
Neurourology and Urodynamics, 40(2), 714-721. Wiley-Liss Inc.
Neurourology and Urodynamics
Neurourology and Urodynamics, 40(2), 714-721. Wiley
Neurourology and urodynamics
Neurourology and Urodynamics, 40(2), 714-721. Wiley-Liss Inc.
Neurourology and Urodynamics
Author(s): Pezzella, Andrea; McCrery, Rebecca; Lane, Felicia; Benson, Kevin; Taylor, Chris; Padron, Osvaldo; Blok, Bertil; de Wachter, Stefan; Gruenenfelder, Jennifer; Pakzad, Mahreen; Perrouin-Verbe, Marie-Aimee; van Kerrebroeck, Philip; Mangel, Jef
Autor:
Sean W. Berquist, Chen Shenhar, Stefanie van Uem, Ashu Mohammad, Abdelrahman S. Abdalla, Craig V. Comiter, Raveen Syan, Eboo Versi, Amy D. Dobberfuhl
Publikováno v:
Journal of Urology. 207
Autor:
Craig V. Comiter
Publikováno v:
The Urologic clinics of North America. 49(2)
Autor:
Ericka Sohlberg, Chiyuan A. Zhang, Daniel R. Greenberg, Craig V. Comiter, Ekene Enemchukwu, Veronica Santini
Publikováno v:
Urology. 144:99-105
Objective To assess the efficacy, safety, and outcomes of sacral nerve stimulation (SNS) for Parkinson's disease (PD) patients with overactive bladder symptoms. Methods We retrospectively reviewed PD patients who underwent Stage I SNS. Demographics,
Autor:
Jennifer Gruenenfelder, Philip Van Kerrebroeck, Mahreen Pakzad, Loïc Le Normand, Bertil F.M. Blok, Una Lee, Margaret G. Mueller, Osvaldo Padron, Jeffrey Mangel, Michael J. Kennelly, Stefan De Wachter, Rebecca McCrery, Kenneth M. Peters, Kevin Benson, Andrea Pezzella, Marie Aimée Perrouin-Verbe, Chris Taylor, Howard B. Goldman, Felicia Lane, Craig V. Comiter, Andrew Shapiro
Publikováno v:
Journal of Urology, 203(1), 185-192. Elsevier Inc.
Journal of Urology, 203(1), 185-191. Elsevier Inc.
The journal of urology
Journal of Urology, 203(1), 185-191. Elsevier Inc.
The journal of urology
Purpose: Sacral neuromodulation is a guideline recommended treatment of urinary dysfunction and fecal incontinence in patients in whom conservative treatments have failed. Historically sacral neuromodulation has been delivered using a nonrechargeable